Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.81%) $83.17
Gas
(1.14%) $1.945
Gold
(-0.25%) $2 341.40
Silver
(0.13%) $27.57
Platinum
(0.79%) $929.40
USD/EUR
(-0.28%) $0.932
USD/NOK
(-0.35%) $10.99
USD/GBP
(-0.38%) $0.797
USD/RUB
(0.25%) $92.11

Echtzeitaktualisierungen für Panacea Biotec Limited [PANACEABIO.NS]

Börse: NSE Sektor: Healthcare Industrie: Biotechnology
Upcoming Earnings Alert

Quarter results today
(bmo 2024-04-29)

Expected move: +/- 4.66%

Zuletzt aktualisiert29 Apr 2024 @ 06:37
25% discount on Stockinvest.us - Use code: Podcast

0.42% INR 144.25

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 06:37):

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India...

Stats
Tagesvolumen 21 674.00
Durchschnittsvolumen 199 373
Marktkapitalisierung 8.84B
EPS INR0 ( 2024-04-05 )
Last Dividend INR0.750 ( 2011-09-19 )
Next Dividend INR0 ( N/A )
P/E -72.12
ATR14 INR0.280 (0.19%)

Volumen Korrelation

Lang: 0.05 (neutral)
Kurz: -0.33 (neutral)
Signal:(41.513) Neutral

Panacea Biotec Limited Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Panacea Biotec Limited Korrelation - Währung/Rohstoff

The country flag 0.70
( moderate )
The country flag 0.65
( moderate )
The country flag 0.00
( neutral )
The country flag 0.70
( moderate )
The country flag 0.08
( neutral )
The country flag -0.62
( weak negative )

Panacea Biotec Limited Finanzdaten

Annual 2022
Umsatz: INR4.60B
Bruttogewinn: INR2.07B (45.07 %)
EPS: INR-5.51
FY 2022
Umsatz: INR4.60B
Bruttogewinn: INR2.07B (45.07 %)
EPS: INR-5.51
FY 2022
Umsatz: INR6.59B
Bruttogewinn: INR3.59B (54.49 %)
EPS: INR175.98
FY 2021
Umsatz: INR6.18B
Bruttogewinn: INR3.89B (63.00 %)
EPS: INR-24.11

Financial Reports:

No articles found.

Panacea Biotec Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A) 		INR0
(N/A)

Panacea Biotec Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.993 - No dividend growth expected in the near future
Information
First Dividend INR1.000 2002-08-13
Last Dividend INR0.750 2011-09-19
Next Dividend INR0 N/A
Payout Date 2011-10-10
Next Payout Date N/A
# dividends 9 --
Total Paid Out INR8.50 --
Avg. Dividend % Per Year 0.00% --
Score 0.72 --
Div. Sustainability Score 0
Div.Growth Potential Score 0.993
Div. Directional Score 0.446 --
Next Divdend (Est)
 (2024-05-17)
INR0 Estimate 0.00 %
Dividend Stability
0.02 Very Bad
Dividend Score
0.72
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2002 INR0 0.00%
2003 INR0 0.00%
2004 INR0 0.00%
2005 INR0 0.00%
2006 INR0 0.00%
2007 INR0 0.00%
2008 INR0 0.00%
2009 INR0 0.00%
2010 INR0 0.00%
2011 INR0 0.00%
2012 INR0 0.00%
2013 INR0 0.00%
2014 INR0 0.00%
2015 INR0 0.00%
2016 INR0 0.00%
2017 INR0 0.00%
2018 INR0 0.00%
2019 INR0 0.00%
2020 INR0 0.00%
2021 INR0 0.00%
2022 INR0 0.00%
2023 INR0 0.00%
2024 INR0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RITES.NS Dividend Knight 2023-09-08 Quarterly 7 3.95%
LAMBODHARA.NS Dividend Junior 2023-09-14 Annually 10 0.87%
FORCEMOT.NS Dividend Junior 2023-09-21 Annually 6 0.45%
APLAPOLLO.NS Ex Dividend Junior 2023-09-01 Sporadic 13 0.07%
TATVA.NS Dividend Junior 2023-09-08 Annually 3 0.04%
NUCLEUS.NS Dividend Junior 2023-07-07 Annually 22 1.41%
INDUSINDBK.NS Dividend Junior 2023-06-02 Annually 23 0.56%
COLPAL.NS Dividend Knight 2023-05-19 Semi-Annually 18 1.38%
SBIN.NS Dividend Junior 2023-05-31 Sporadic 29 0.99%
MAHSEAMLES.NS Dividend Junior 2023-08-14 Annually 21 0.80%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.02221.500-0.445-0.667[0 - 0.5]
returnOnAssetsTTM01.20000[0 - 0.3]
returnOnEquityTTM-0.01451.500-1.273-1.909[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM00.800-5.00-4.00[1 - 3]
quickRatioTTM00.800-4.71-3.76[0.8 - 2.5]
cashRatioTTM01.500-1.111-1.667[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM2.631.000-0.137-0.137[3 - 30]
operatingCashFlowPerShareTTM12.222.005.9310.00[0 - 30]
freeCashFlowPerShareTTM12.222.003.897.78[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.4841.0005.275.27[0.2 - 0.8]
operatingProfitMarginTTM-0.1071.000-4.14-4.14[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score-0.101

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-71.711.000-7.340[1 - 100]
returnOnEquityTTM-0.01452.50-0.818-1.909[0.1 - 1.5]
freeCashFlowPerShareTTM12.222.005.937.78[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM12.222.005.9310.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.4791.500-6.530[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1361.0009.110[0.1 - 0.5]
Total Score0.993

Panacea Biotec Limited

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceuticals, vaccines, and biosimilars in India. It operates through Vaccines and Formulations segments. The company's product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care; and vaccines for anthrax, dengue, Japanese encephalitis, and others. It also exports its products to over 30 countries worldwide, including the United States, Germany, the Russian Federation, Sri Lanka, the Philippines, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. Panacea Biotec Limited was incorporated in 1984 and is based in New Delhi, India.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.